scholarly journals Failure of desmopressin to lower serum sodium or prevent crisis in patients with sickle cell anemia

Blood ◽  
1981 ◽  
Vol 58 (5) ◽  
pp. 892-896
Author(s):  
S Charache ◽  
WG Walker

An analogue of arginine vasopressin (desmopressin, DDAVP) was evaluated for production chronic hyponatremia and prevention of sickle cell crisis. With sodium restriction (100 meq Na + / day) and water loading ( greater than 3 liters/day), persistent hyponatremia could not be achieved, nor could crises be prevented or aborted. Patients would not comply with a regimen of lower salt and higher fluid intake. More rigorous treatment might be practical during acute sickle cell crises, and a regimen similar to that used here might be more effective in children, whose renal concentrating mechanisms are still intact.

Blood ◽  
1981 ◽  
Vol 58 (5) ◽  
pp. 892-896 ◽  
Author(s):  
S Charache ◽  
WG Walker

Abstract An analogue of arginine vasopressin (desmopressin, DDAVP) was evaluated for production chronic hyponatremia and prevention of sickle cell crisis. With sodium restriction (100 meq Na + / day) and water loading ( greater than 3 liters/day), persistent hyponatremia could not be achieved, nor could crises be prevented or aborted. Patients would not comply with a regimen of lower salt and higher fluid intake. More rigorous treatment might be practical during acute sickle cell crises, and a regimen similar to that used here might be more effective in children, whose renal concentrating mechanisms are still intact.


1981 ◽  
Vol 27 (2) ◽  
pp. 314-316 ◽  
Author(s):  
E F Roth ◽  
P A Bardfeld ◽  
S J Goldsmith ◽  
E Radel ◽  
J C Williams

Abstract Data on plasma hydroxybutyrate dehydrogenase activity (I) and myoglobin concentration were used to evaluate painful sickle cell crises. I was increased during non-crisis steady state in patients with sickle cell disease as compared to normal values (232, SD 79.7 vs 85, SD 33 Sigma units/mL). During crisis, the mean value for I increased further to 379 (SD 139) Sigma units/mL. For 12 patients evaluated both during steady state and crisis, there was a mean increase in plasma I of 131% (SD 76%). Repeated determinations of I in sickle cell disease patients during several months while they were in steady state showed that baseline I varied by no more than 20% from the mean. Plasma myoglobin in patients with sickle cell disease was not above normal, but during crisis 21 of 39 patients tested had increased plasma myoglobin concentrations. Our data suggest that I may be a useful indicator of sickle cell crisis when the patient's own baseline value is available for comparison. Plasma myoglobin measurements give evidence of muscle damage during crisis with high specificity but low sensitivity.


Blood ◽  
1962 ◽  
Vol 20 (1) ◽  
pp. 19-32 ◽  
Author(s):  
LAWRENCE E. PIERCE ◽  
CHARLES E. RATH

Abstract Two cases are presented of sickle cell anemia demonstrating evidence of folic acid deficiency during a period of anemic crisis. One patient had acute hypoplastic crisis associated with megaloblastic erythropoiesis not in conjunction with acute infection, dietary inadequacy, gastrointestinal malabsorption or chronic alcoholism. An increased excretion of urinary formiminoglutamic acid of 8.8 µM/hr. after histidine stimulation was observed in association with more severe anemia than had been noted previously during nine years observation. Prompt reticulocytosis and rise in hematocrit to previous levels occurred when 1 mg. oral daily folic acid was administered. Improvement was accompanied by a fall in FIGlu excretion to normalcy. Since the observation of folic acid responsiveness in this patient, it has not been necessary to transfuse him for a period in excess of 15 months whereas his previous average requirement approached one unit each month for the past seven and one-half years. A second patient demonstrated increased formiminoglutamicaciduria coincident with anemic sickle cell crisis following bilateral bronchopneumonia with pulmonary thrombosis. There was a beneficial hematologic response to oral folic acid supplementation in physiologic doses. Previously determined control urinary FIGlu levels had been within normal limits. Increased urinary FIGlu has been observed in five additional sickle cell patients not in anemic crisis. One of these (V. K.) was tested for sensitivity to higher dosage levels of folic acid (5 mg. each day) without improvement. Low levels of FIGlu-like material persisted in some patients with sickle cell anemia after treatment with folic acid. Indirect evidence would indicate that this material is urocanic acid and may be related to the chronic liver dysfunction frequently present in sickle cell disease. Evidence has been presented which indicates that folic acid may be a limiting factor in the development of and recovery from anemic sickle cell crisis.


Blood ◽  
1977 ◽  
Vol 49 (6) ◽  
pp. 967-979 ◽  
Author(s):  
EE Rieber ◽  
G Veliz ◽  
S Pollack

Abstract The pathophysiology of the occurrence and resolution of sickle cell crisis is unknown. The molecular abnormality is constant, while crisis is episodic. In the present study, red cell filterability and sickling with deoxygenation have been measured during sickle cell crises. Recovery from sickle crisis is associated with an increased filterability of the circulating red cell and a decreased susceptibility of the red cell to sickle with deoxygenation (p less than 0.05). The possibility that these changes are responsible for the resolution of crisis is suggested.


Blood ◽  
1982 ◽  
Vol 60 (6) ◽  
pp. 1411-1419 ◽  
Author(s):  
PF Milner ◽  
M Brown

Abstract Bone marrow infarction was investigated by 99mTc-sulfur colloid imaging in 42 patients with sickle cell anemia (SS) over a period of 2 yr. Marrow defects were demonstrated in 28 patients (66.6%), and in 15 (aged 19--52 yr), they were matched by roentgenographic evidence of medullary bone infarction. Repeated images showed no change in the size or site of these defects. Among 13 patients (aged 6--32 yr), all in crisis when initially examined, marrow defects were not associated with roentgenographic changes, and in many cases, repeated images showed resolution or decrease in size of the defects in 3--6 mo, even if the limb had been swollen and the marrow defect large. Among 14 patients (aged 18--36 yr), all asymptomatic at the time of study, no defects were found. Comparison of hematologic variables revealed a higher mean hemoglobin and hematocrit level among those with marrow infarcts (p less than 0.0001). High levels of HbF, or the presence of alpha- thalassemia, did not protect against marrow infarction. Pulmonary fat embolism was not observed. 99mTc-sulfur colloid marrow imaging was considered to provide more useful information in the initial management of bone pain and swelling in sickle cell crisis than either roentgenographs or conventional 99mTc-methyldiphosphate bone images.


2021 ◽  
Vol 10 (4) ◽  
pp. 3388-3393
Author(s):  
Monali Rajendra kumar Sahu

Sickle cell hemoglobinopathy patients are vexed with sickle cell crises crises all through their life. Occurrence of jaundice in these patients is quite common and when present gets ascribed to the sickle cell crisis, sickle cell hepatopathy, intrahepatic cholestasis or cholelithisis. Further, incidence of viral hepatitis is extremely common in these patients. Clinically it is difficult to distinguish this aetiology. We have attempted to identify the criteria to help differentiate amongst sicklers which patients should be investigated for viral hepatitis. Also, sicklers with hepatitis have been studied against non sicklers with hepatitis and also complications of hepatitis in these two groups.


Blood ◽  
2019 ◽  
Vol 134 (Supplement_1) ◽  
pp. 4858-4858
Author(s):  
Krithika Shanmugasundaram ◽  
Ixavier Higgins ◽  
Fuad A El Rassi ◽  
Morgan L. McLemore

Background: In sickle cell anemia, very few markers of disease have been shown to correlate with activity and severity of crisis. We aimed to identify any patterns amongst biomarkers and co-morbidities that correlate with death from multi-organ failure when admitted for sickle cell crisis. Methods: We identified 20 patients with sickle cell anemia who died of multi-organ failure at Grady Memorial Hospital from 2010-2016. We described baseline characteristics, such as hemoglobin phenotype, age, gender as well as features at presentation such as vital signs, laboratory data, clinical signs and symptoms (I.e. worsening pain), and co-morbidities. We examined bivariate associations between clinical characteristics and the length of survival after multi-organ failure. In a secondary analysis, we investigated clinical and demographic features that most accurately predict infection with gram-negative bacteria. To achieve this, we fit a multivariate logistic regression model and perform leave-one-out cross validation to assess the predictive performance of the fitted model on unseen data. Results: At baseline, the average age of a patient is 43.8 years (sd=14.7 years). A majority of our cohort are women (60%), do not smoke (70%), and were not on hydroxyurea (80%). Time to death from multi-organ failure was 3.05 days (95% C.I.: 0.20, 5.90), and only 43% identified having "worsening pain." Among complications, 23% had a stroke and 25% had an infection with gram-negative bacteria. With regards to laboratory data, average WBC was 13.4 (95% C.I.: 11.04, 15.70), Platelets 155 (95% C.I.: 102.22, 208.38), d-dimer 12,892 (95% C.I.: -2498.47, 33437.87) and ferritin 3108 (95% C.I.: 795.07, 5421.63). When using a univariate analysis, we identified that stroke (p=0.008), age (p=0.022) and platelet count at the time of presentation (p=0.039) correlated with time to death. We also identified a statistically significant decrease in the platelet count from baseline to time of multi-organ failure (-105.6, p<0.001). Body mass index (BMI) and worsening pain jointly predict infection with gram-negative bacteria with small error (0.133). Conclusion: We have described a cohort of patients with sickle cell anemia who died of multi-organ failure and found that some factors may have correlated with time to death. The most poignant factors include age, platelet count, and drop in platelet count from baseline. It is also interesting that a proportion of these patients developed a gram-negative bacterial infection, which is a common cause of mortality in sepsis. Although our cohort is small, these data may help guide future studies with larger cohorts of patients to identify what puts these patients at risk of death from multi-organ failure. Disclosures No relevant conflicts of interest to declare.


2005 ◽  
Vol 19 (2) ◽  
pp. 83-86 ◽  
Author(s):  
Arnon Blum ◽  
Shay Yeganeh ◽  
Aviva Peleg ◽  
Fina Vigder ◽  
Konstantin Kryuger ◽  
...  

1993 ◽  
Vol 21 (01) ◽  
pp. 85-89 ◽  
Author(s):  
Joseph Sodipo

The author recently treated a case of sickle-cell crisis as an emergency for pain relief using acupuncture because all other conventional therapies failed. The result was so effective, dramatic and encouraging that four other cases of genotype SS/SC were also treated. These cases are reported, (though small in number) to bring attention to this easy, simple, cheap and convenient therapy and to stimulate research among practicing acupuncturists and clinicians.


2009 ◽  
Vol 4 (6) ◽  
pp. 532-535 ◽  
Author(s):  
Nader S. Dahdaleh ◽  
Timothy E. Lindley ◽  
Patricia A. Kirby ◽  
Hiroyuki Oya ◽  
Matthew A. Howard

The occurrence of spontaneous acute epidural hematomas is rare in patients with sickle cell disease. The authors report the case of a patient with sickle cell anemia who presented with a sickle cell crisis that was complicated by the development of multiple acute epidural and subgaleal hematomas requiring surgical evacuation. Possible underlying mechanisms are discussed. Although rare, clinicians should be aware of this phenomenon as part of a spectrum of neurological complications in these patients.


Sign in / Sign up

Export Citation Format

Share Document